Podcasts about ohsu

Guest: Marcus Hwang MD DDS https://www.instagram.com/dr_marcushwang/?hl=en   Host: Serv Wahan MD DMD https://www.drwahan.com/     keywords   dentistry, oral surgery, residency, study tips, medical education, CBSE, dental school, private practice, MD programs, patient care; ANKI,  USMLE, study methods, pathoma, OHSU, First Aid study book, sketchy pharm, sketchy microbiology, Marcus Hwang, Dr Wahan     takeaways Dr. Marcus shares his unique journey from aspiring pastor to oral surgeon. The importance of mentorship and networking in dental school and residency. Study strategies like spaced repetition can significantly enhance exam preparation. Hands-on experience in externships is crucial for dental students. Understanding the healthcare system is vital for new residents. The transition from dental school to residency can be challenging but rewarding. People skills are as important as clinical skills in dentistry. The future of MD integrated programs is uncertain and requires discussion. Financial considerations play a significant role in career decisions for dental professionals. Continuous learning and adaptation are key to success in the medical field.   summary   In this engaging conversation, Dr. Marcus shares his unique journey from aspiring pastor to oral surgeon, discussing the challenges and triumphs of dental school and residency. He emphasizes the importance of mentorship, study strategies, and the role of people skills in dentistry. The discussion also touches on the future of MD integrated programs, financial considerations in career decisions, and the evolving landscape of oral surgery residency programs.     titles From Pastor to Oral Surgeon: Dr. Marcus's Journey Navigating Dental School and Residency: Tips and Insights   Sound Bites "I always wanted to be a pastor." "I'd rather grind for one year to get in now." "Med school is paid for through an endowment."   Chapters 00:00 Introduction and Name Confusion 02:53 From Pastor to Dentist: A Journey of Discovery 05:50 The Shift to Oral Surgery: Finding Passion 08:55 Navigating Dental School and Residency Preparation 11:54 Study Techniques for Success in Dental School 14:55 Resources for Studying: Digital vs. Physical 17:52 The Transition to Residency: Challenges and Experiences 20:47 Final Thoughts on the Journey to Oral Surgery 27:11 Transitioning from Dental to Medical Practice 30:03 Navigating Residency Challenges 36:51 The Future of Oral Surgery 41:42 The Importance of People Skills 46:42 Reflections on Medical Education and Debt 52:14 Endowments and Financial Support in Medical Training

Welcome back our series on AI for the clinician! In this episode, we go over some basics of machine learning statistics with the goal to help you read and analyze contemporary studies. Some of this will be a review, and parts will be technical, but by the end we hope reading these studies is less daunting.  Hosts: Ayman Ali, MD Ayman Ali is a Behind the Knife fellow and general surgery PGY-4 at Duke Hospital in his academic development time where he focuses on data science, artificial intelligence, and surgery.  Julie Doberne, MD, PhD: @juliedoberne Julie Doberne is an Assistant Professor of Surgery, Assistant Professor of Medical Informatics and Clinical Epidemiology, cardiothoracic surgeon, and faculty member of the Surgical Data and Decision Sciences Lab at Oregon Health and Science University.  Phillip Jenkins, MD: @PhilJenkinsMD Phil Jenkins is a general surgery PGY-4 at Oregon Health and Science University and a National Library of Medicine Post-Doctoral fellow pursuing a master's in clinical informatics.  Steven Bedrick, PhD: @stevenbedrick Steven Bedrick is a machine learning researcher and an Associate Professor in Oregon Health and Science University's Department of Medical Informatics and Clinical Epidemiology.  Shelby Willis, MD Shelby Willis is a general surgery PGY-4 at Oregon Health and Science University. She is currently in her research time in the Surgical Data and Decision Sciences lab at OHSU pursuing advanced training in informatics. Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listen BTK Fan Favorites:  General Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-review Trauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlas Dominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkship Download our App: Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049 Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US

Send us a textIn this episode of The Incubator Podcast, we welcome Dr. Cindy McEvoy, Professor of Pediatrics and Director of Neonatal Research at OHSU, to discuss her work on the use of extended CPAP in preterm infants. CPAP has long been a cornerstone of neonatal care, but how long should stable infants remain on support? Dr. McEvoy shares findings from two randomized controlled trials that explored whether an additional two weeks of CPAP could promote lung growth and improve longer-term outcomes.We review the physiologic rationale behind extended CPAP, including the role of mechanical stretch in stimulating alveolar and vascular development. Dr. McEvoy explains the stability criteria used to determine eligibility for extended CPAP and how her team measured pulmonary function in neonates. Results from her studies showed significant improvements in lung volume, diffusion capacity, and expiratory flows, with early signals of reduced wheezing at one year of age.The conversation also touches on feeding tolerance, the practicalities of implementing extended CPAP in the NICU, and the need for larger multicenter studies to confirm these findings. This episode offers an evidence-based look at how a simple extension of an existing therapy might reshape respiratory outcomes for preterm infants.Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

The Food and Drug Administration approved the sale of over-the-counter birth control pills two years ago. The decision has dramatically increased access to contraception, according to a new study from Oregon Health & Science University.    Researchers found that more than a quarter of participants who were using the over-the-counter pill had switched from using no birth control at all. They also found that members of the over-the-counter group were more likely to be uninsured and live in rural areas than participants who used prescription birth control.   Maria Rodriguez is the director of both the Center for Reproductive Health Equity and the Center for Women’s Health at OHSU. She joins us with more on the importance of removing barriers to reproductive health care.  

What if your bleeding gums could be the reason you can't get pregnant—or why your brain is at risk of Alzheimer's? In this groundbreaking conversation with functional dentist Dr. Staci Whitman, we uncover how your oral microbiome impacts far more than just your smile. From fertility struggles and pregnancy loss to Alzheimer's, cancer, and even depression, the bacteria in your mouth may be silently shaping your entire health span. Dr. Whitman breaks down the science of “leaky gums,” reveals why saliva is the body's golden elixir, and explains how simple shifts in diet, hygiene, and oral microbiome testing could change the future of medicine. This is not just about teeth—it's about your brain, hormones, longevity, and life itself.About Dr. Staci Whitman: Dr. Staci Whitman is a board-certified pediatric dentist and founder of NoPo Kids Dentistry in Portland, Oregon, where she practices a whole-body, functional approach to children's oral health. A graduate of Tufts University and OHSU, she has specialized expertise in sleep, airway health, and myofunctional therapy. Dr. Staci is also a Diplomate of the American Board of Pediatric Dentistry, a Breathe Institute Ambassador, and an active member of several holistic and biological dentistry organizations. Her mission is simple yet powerful: to create a world without cavities and to empower families with practical, science-backed tools for lifelong health. *** Subscribe to The Neuro Experience for more conversations at the intersection of brain science and performance. I'm committed to bringing you evidence-based insights that you can apply to your own health journey. *** A huge thank you to my sponsors for supporting this episode. Check them out and enjoy exclusive discounts: Function Health: The first 1000 get a $100 credit toward their membership. Visit www.functionhealth.com/louisanicola and use code NEURO100 or use gift code NEURO100 at sign-up to own your health. Boncharge: Go to www.boncharge.com | Code: NEURO15 for 15% off FIGS: You can get 15% off your first order at https://wearfigs.com with the code FIGSRX.  Manukora: Head to www.manukora.com/neuro to save up to 31% plus $25 worth of free gifts with the Starter Kit. Cozy Earth Head to cozyearth.com and use my code NEURO for 40% off!  Rula Go to Rula.com/NEURO to get started today. For convenient therapy that's covered by insurance.  *** I'm Louisa Nicola — clinical neuroscientist — Alzheimer's prevention specialist — founder of Neuro Athletics. My mission is to translate cutting-edge neuroscience into actionable strategies for cognitive longevity, peak performance, and brain disease prevention. If you're committed to optimizing your brain — reducing Alzheimer's risk — and staying mentally sharp for life, you're in the right place. Stay sharp. Stay informed. Join thousands who subscribe to the Neuro Athletics Newsletter → https://bit.ly/3ewI5P0 Instagram: https://www.instagram.com/louisanicola_/ Twitter : https://twitter.com/louisanicola_ Topics discussed: 00:00:00 Oral health, gum disease & fertility connection 00:02:46 Inflammation & systemic effects 00:06:00 Defining true oral health (nutrition, saliva, airway) 00:08:25 Diet, processed foods & cavities 00:15:00 Saliva, dry mouth & gut health 00:19:49 Oral microbiome testing & treatments 00:24:17 Treatment plan, family transmission & genetics 00:26:30 Alzheimer's, brain health & strokes 00:33:07 Oral health & cancer links 00:41:50 Inflammation causing pancreatic cancer 00:42:27 Failing dental work and cancer 00:43:37 Fertility & Menopause 00:46:31 Spit test & depression/mood disorders 00:48:39 Oral health toolkit & practical hygiene tips Learn more about your ad choices. Visit megaphone.fm/adchoices

The number of cannabis-related reports to poison control centers across the U.S. has risen greatly since 2009, according to new reporting from the New York Times. They also found a rise in cases where cannabis poisoning led to breathing problems and even life-threatening effects, especially among teens and adults. Rob Hendrickson is the medical director of the Oregon Poison Center at OHSU. He joins us to share what he’s seen in the emergency room in recent years.

Phil and Penny Knight have pledged $2 billion to Oregon Health & Science University for cancer research. The Knight Cancer Institute will become self-governed within OHSU and will have its own board of directors. In December, renowned cancer researcher Brian Druker announced his resignation as the institute’s CEO but said last week he will return as the inaugural president of the organization. He joins us with details about what this means for cancer care in Oregon.

Around one in 10 youth enrolled in Medicaid spent days stuck in the emergency room after being admitted for a mental health crisis. That’s according to a new study from Oregon Health and Science University. John McConnell is a professor in emergency medicine and the director of the center for health systems at OHSU. Rebecca Marshall is a professor in child and adult psychiatry with OHSU. She is also a practicing psychiatrist at Doernbecher Children's Hospital and Doernbecher emergency department. They both join us to share more on the study and what it means for the kids waiting to be admitted.

The first tropical storm of the season Erin is expected to be a category 4 hurricane and hit parts of the Caribbean. Nike co-founder donated $2 billion to the OHSU's Knight cancer center. The first Robot Olympics is taking place in China!See omnystudio.com/listener for privacy information.

Dr. David Carsten joins little teeth, BIG Smiles host Dr. Joel Berg for a conversation on waterline safety. A previous Chair of Infection Control for the Washington State Dental Commission, Dr. Carsten shares information on how waterlines can be compromised and what practitioners can do to maintain waterline safety to protect their patients and themselves. Guest Bio: David Carsten, DDS, is a dentist anesthesiologist. He has a BS in Biochemistry from Washington State University, with a background in Medical Bacteriology and virology. His DDS is from the University of Washington. He has 5 publications in the scientific literature. He received the Award of Distinction in Continuing Education from the Academy of Dentistry International in 2005. He lectures often, internally and externally, on many topics. For example, Dave did more than 30 lectures regarding the COVID-19 pandemic from 10 January 2020 to the present and has consulted dentists and entities regarding mitigation. He is an Assistant Professor in Hospital Dentistry at Oregon Health Sciences University, General Practice Residency program. That program focuses on patients that fall within the broad definition of special needs and are thirteen years old or older. He was on the ADA Steering Committee for the DLOSCE. He mentors the interdisciplinary lecture group at OHSU, the Tilikum Crossing Seminar Series. He is a Chair for the Department of Health, Washington State Dental Commission, also chairing the Infection Control Committee. Dave lives in Vancouver with his wife, Sharon, his son, Davin, and their dog, Kiki. He has been a member of the Spiritual Care Team at Salmon Creek Legacy Hospital since 2012.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Join us for a fascinating conversation about delirium work up and management in a primarily inpatient setting with OHSU consult liaison psychiatrists Dr. Kamalika Roy and Dr. Jonathan Floriani.

Morning news, a medical school for Medford? (more pill pushing or gender surgeries?) It would be in conjunction with OHSU. Mark J. Quann, author of Be Smart Pay Zero Taxes - Use the Buy, Borrow, Die Strategy to Get Rich and Stay Rich

Dr. Luiz E. Bertassoni is the founding director of the Knight Cancer Precision Biofabrication Hub and Professor in the Division of Oncological Sciences at the Knight Cancer Institute, where he is also co-section head for Discovery and Translational Oncology. He is also faculty in the Department of Biomedical Engineering, the Cancer Early Detection Advanced Research (CEDAR) Center, and the Oregon Health and Sciences University (OHSU) School of Dentistry. Luiz is co-founder of 2 biotech spin-off companies which resulted from his work on cancer research and regenerative medicine: he is Co-Founder and Chief Technology Officer of HuMarrow and Co-Founder and Chief Medical Officer of RegendoDent. Outside of science, Luiz is a big fan of surfing, and he enjoyed frequent trips to the beach while completing his PhD in Sydney, Australia, and a postdoctoral fellowship in San Francisco, California. In addition to spending time in the water, Luiz loves music. He is a singer-songwriter who plays various instruments, including guitar, drums, bass, and piano. In his research, Luiz applies engineering tools to biology to build human tissues in the lab. The goal of Luiz's lab is to create new models to better understand cancers and develop methods to regenerate lost or damaged tissues. Luiz was awarded his Doctor of Dental Surgery (DDS) degree from the Pontifical Catholic University of Parana in Brazil. Afterwards, he conducted postdoctoral research at the University of California, San Francisco. He then enrolled in a graduate program and received his PhD in Biomaterials from the University of Sydney. Next he accepted a postdoctoral fellowship in Harvard Medical School and MIT's joint program in Health Sciences and Technology. He served on the faculty at the University of Sydney before joining the faculty at OHSU in 2015. His work on vascular bioprinting was listed in the top 100 research discoveries by Discover Magazine, and he has received over 30 national and international research awards, including the Medical Research Foundation New Investigator award, the Silver Family Faculty Innovation award, and many others. In this interview, Luiz shares more about his life and science.

Superpowers for Good should not be considered investment advice. Seek counsel before making investment decisions. When you purchase an item, launch a campaign or create an investment account after clicking a link here, we may earn a fee. Engage to support our work.Watch the show on television by downloading the e360tv channel app to your Roku, AppleTV or AmazonFireTV. You can also see it on YouTube.Devin: What is your superpower?Nicole: Willingness to take bold leaps and embrace the unknown.Imagine a world where cancer is as treatable as the flu. That's the vision Nicole Paulk, the founder and CEO of Siren Biotechnology, is working tirelessly to bring to life. Driven by groundbreaking science, Nicole's company is on the brink of launching clinical trials for a revolutionary cancer treatment.Nicole's work leverages engineered viruses—those that don't make you sick—to deliver genetic medicines directly to cancer cells. These “good viruses” act as a delivery system for anti-tumor drugs, targeting difficult-to-treat cancers like recurrent high-grade gliomas, a fatal brain cancer. “We started to see data that looked really promising in this space,” Nicole explained, adding, “We felt a moral obligation to go after this cancer where there's just this huge unmet need.”Siren Biotechnology's approach is designed to have broad applications. Unlike treatments that target specific genetic mutations, their method has the potential to work on various tumor types. Nicole describes it as using viruses like a “little FedEx delivery truck” that can be engineered to deliver medicine precisely where it's needed in the body.This innovation didn't happen overnight. Nicole, a former professor of virology at UCSF, took the bold step of leaving academia to launch Siren Biotechnology. “I decided to resign from my faculty position and go be the founder and CEO just because I was so excited about the data and what we had so far,” she shared.In addition to traditional venture capital funding, Siren Biotechnology is inviting the public to invest through a regulated investment crowdfunding campaign. This unique opportunity allows patients, families, and supporters touched by cancer to be part of their journey. “We wanted to bring patients and their families onto our cap table,” Nicole said. “It's a way to involve them in the conversation much earlier.”Siren Biotechnology's work could redefine cancer care and inspire a new model for patient-centered innovation. With clinical trials just months away, the future looks brighter for those battling cancer—and for all of us who dream of a world where cancer is no longer a death sentence.tl;dr:Nicole Paulk's Siren Biotechnology transforms viruses into targeted cancer therapies with universal potential.The company focuses on recurrent high-grade gliomas, a fatal brain cancer with no standard treatment.Nicole left academia to lead Siren, leveraging her groundbreaking virology research to launch the company.Siren's unique crowdfunding campaign lets patients and families invest in the fight against cancer.Nicole's superpower, fearless innovation, drives her bold mission to revolutionize cancer care.How to Develop Fearless Innovation As a SuperpowerNicole's superpower is her willingness to take bold leaps and embrace the unknown. After spending nearly two decades building her academic career, Nicole left her position as a virology professor at UCSF to start Siren Biotechnology. She explained, “I feel like my superpower is just kind of being willing to jump off the cliff without a parachute and be like, we're going to figure it out. We're going to make it work.”Nicole exemplified fearless innovation when her research led to a groundbreaking discovery about the biology of a virus, one that required rewriting existing textbooks. Initially met with skepticism, her work was later validated and became a foundation for Siren Biotechnology's cancer treatment. This pivotal moment highlights Nicole's courage to challenge conventional knowledge and pursue transformative ideas.Tips for Developing This Superpower:Be willing to question conventional wisdom and explore new paths.Take calculated risks, even if it means stepping away from a well-defined career path.Embrace discomfort and uncertainty as a necessary part of innovation.Engage others by communicating your vision in relatable and accessible ways.By following Nicole's example and advice, you can make fearless innovation a skill. With practice and effort, you could make it a superpower that enables you to do more good in the world.Remember, however, that research into success suggests that building on your own superpowers is more important than creating new ones or overcoming weaknesses. You do you!Guest ProfileNicole Paulk (she/her):CEO, Founder, President, Siren BiotechnologyAbout Siren Biotechnology: We are combining two transformative therapeutic technologies – AAV gene therapy and cytokine immunotherapy – into a single, reimagined modality that overcomes key challenges and redefines how we destroy tumor cells and elicit anti-tumor immunity.This is the first AAV gene therapy drug product that can be made once and used in numerous indications – a huge leap forward for the field. This drastically reduces clinical development times, manufacturing timelines, and capital needs for each clinical trial. Most importantly, ‘universal' means countless solid tumor cancer patients – regardless of tumor type or mutations – may benefit from this breakthrough approach.Website: sirenbiotechnology.comX/Twitter Handle: @SirenBioCompany Facebook Page: facebook.com/SirenBiotechnologyOther URL: wefunder.com/siren.biotechnologyBiographical Information: Dr. Nicole Paulk is the CEO, Founder, and President of Siren Biotechnology and has dedicated her career to advancing the field of gene therapy. With nearly two decades of expertise, Nicole has been at the forefront of developing cutting-edge advances to propel the field of gene therapy forward for a wide range of diseases.Before founding Siren, Nicole held various leadership positions in academia and industry and most notably was an Assistant Adj Professor of AAV Gene Therapy in the UCSF Department of Biochemistry & Biophysics before leaving to found Siren. Nicole has a B.S. in Medical Microbiology, a Ph.D. in Viral Gene Therapy and Regenerative Medicine from OHSU, and completed her Postdoctoral Fellowship and Instructorship in Human Gene Therapy at Stanford University prior to starting her lab at UCSF. Nicole is a pioneer in the development of next-generation AAV platforms for gene repair, gene transfer and gene editing, directed evolution for novel engineered capsid evolution, and comparative multi-omic approaches to interrogate translational AAV biology.Nicole is a renowned expert in gene therapy and has consulted extensively for big pharma, written draft CMC guidance for the FDA, and sits on the Scientific Advisory Boards for Sarepta, Astellas, Metagenomi, Dyno Therapeutics, CEVEC, GRO Biosciences, Excision BioTherapeutics, WhiteLab Genomics, Johns Hopkins Gene Therapy Initiative, the Gene Therapy for Rare Disorders Searchlight Program, and several stealth startups. She has been quoted in The Wall Street Journal, The Economist, The Boston Globe, Endpoints, STAT, Phacilitate, GEN, BioPharma Dive, Evaluate Vantage, SF Business Times, WIRED, Drug Discovery World, MIT Tech Review, C&EN, and more. She sits on the Scientific Editorial Boards of the journals Gene Therapy, Human Gene Therapy, and Biopharma International Gene Therapy. She is the Chair of the American Society of Gene and Cell Therapy (ASGCT) Translational Science Committee, and a member of the ASGCT Cancer Cell and Gene Therapy Committee and the Biocom California Cell and Gene Therapy Committee. She has invented numerous AAV gene therapy technologies that have been shared or licensed to dozens of gene therapy companies and nonprofit groups working in rare diseases.Outside of work, you can find Nicole adventure traveling (think whitewater rafting meets backcountry trekking), snowboarding, planning elaborate Halloween parties complete with animatronics and ghoulish menus, tending her vegetable garden, and obsessing over the latest wearable gadgets. If you're trying to track her down at a conference and can't find her, it's because she snuck off to an oyster bar.X/Twitter Handle: @Nicole_PaulkLinkedin: linkedin.com/in/nicolepaulkInstagram Handle: @sirenbioSupport Our SponsorsOur generous sponsors make our work possible, serving impact investors, social entrepreneurs, community builders and diverse founders. Today's advertisers include FundingHope, Kingscrowd and Crowdfunding Made Simple. Learn more about advertising with us here.Max-Impact MembersThe following Max-Impact Members provide valuable financial support:Carol Fineagan, Independent Consultant | Lory Moore, Lory Moore Law | Marcia Brinton, High Desert Gear | Paul Lovejoy, Stakeholder Enterprise | Pearl Wright, Global Changemaker | Ralf Mandt, Next Pitch | Scott Thorpe, Philanthropist | Matthew Mead, Hempitecture | Michael Pratt, Qnetic | Sharon Samjitsingh, Health Care Originals | Add Your Name HereUpcoming SuperCrowd Event CalendarIf a location is not noted, the events below are virtual.Impact Cherub Club Meeting hosted by The Super Crowd, Inc., a public benefit corporation, on June 17, 2025, at 1:00 PM Eastern. Each month, the Club meets to review new offerings for investment consideration and to conduct due diligence on previously screened deals. To join the Impact Cherub Club, become an Impact Member of the SuperCrowd.SuperCrowdHour, June 18, 2025, at 12:00 PM Eastern. Jason Fishman, Co-Founder and CEO of Digital Niche Agency (DNA), will lead a session on "How to Spin $1 of Advertising into $10!" He'll reveal proven strategies and marketing insights drawn from years of experience helping successful crowdfunding campaigns. Whether you're a founder planning a raise or a supporter of innovative startups, you'll gain actionable tips to boost visibility, drive engagement, and hit your funding goals. Don't miss it!Join us on June 25, 2025, at 8:00 PM Eastern for the Superpowers for Good Live Pitch—streaming on e360tv, where purpose-driven founders take the virtual stage to present their active Regulation Crowdfunding campaigns to a national audience of investors and changemakers. Selected startups are chosen for their commitment to community, alignment with NC3's Community Capital Principles, and their drive to create real-world impact. Thanks to sponsors DNA and DealMaker, this event is free to watch and amplifies the voices of underrepresented and mission-aligned entrepreneurs. Don't miss this inspiring evening where capital meets purpose—tune in to discover and support the next wave of impact-driven innovation.SuperCrowd25, August 21st and 22nd: This two-day virtual event is an annual tradition but with big upgrades for 2025! We'll be streaming live across the web and on TV via e360tv. Soon, we'll open a process for nominating speakers. Check back!Community Event CalendarSuccessful Funding with Karl Dakin, Tuesdays at 10:00 AM ET - Click on Events.Devin Thorpe is featured in a free virtual masterclass series hosted by Irina Portnova titled Break Free, Elevate Your Money Mindset & Call In Overflow, focused on transforming your relationship with money through personal stories and practical insights. June 8-21, 2025.Join Dorian Dickinson, founder & CEO of FundingHope, for Startup.com's monthly crowdfunding workshop, where he'll dive into strategies for successfully raising capital through investment crowdfunding. June 24 at noon Eastern. Regulated Investment Crowdfunding Summit 2025, Crowdfunding Professional Association, Washington DC, October 21-22, 2025.Call for community action:Please show your support for a tax credit for investments made via Regulation Crowdfunding, benefiting both the investors and the small businesses that receive the investments. Learn more here.If you would like to submit an event for us to share with the 9,000+ changemakers, investors and entrepreneurs who are members of the SuperCrowd, click here.We use AI to help us write compelling recaps of each episode. Get full access to Superpowers for Good at www.superpowers4good.com/subscribe

Melissa Murphy, MD, Infectious Disease StaffPhysician/HIV Lead Clinician, Portland VA Medical Center; Associate Professor of Clinical Medicine, OHSU; Consultant, Mountain West AIDS Education Training CenterCME Credit Available for all Providence ProvidersIn order to claim CME credit, please click on the following link: https://forms.office.com/r/Kwq9cDjFP5 (or copy & paste into your browser)Accreditation Statement: Providence Oregon Region designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1  creditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.Providence Oregon Region is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.Planning Committee & Faculty Disclosure: The planning committee and faculty have indicated no relevant financial relationships with an ACCME-defined ineligible company. Their planning contributions were evidence-based and unbiased. All financial relationships (if any) have been mitigated.Original Date: June 10, 2025End Date: June 10, 2026

Melissa Murphy, MD, Infectious Disease StaffPhysician/HIV Lead Clinician, Portland VA Medical Center; Associate Professor of Clinical Medicine, OHSU; Consultant, Mountain West AIDS Education Training CenterCME Credit Available for all Providence ProvidersIn order to claim CME credit, please click on the following link: https://forms.office.com/r/Kwq9cDjFP5 (or copy & paste into your browser)Accreditation Statement: Providence Oregon Region designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1  creditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.Providence Oregon Region is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.Planning Committee & Faculty Disclosure: The planning committee and faculty have indicated no relevant financial relationships with an ACCME-defined ineligible company. Their planning contributions were evidence-based and unbiased. All financial relationships (if any) have been mitigated.Original Date: June 10, 2025End Date: June 10, 2026

Welcome back to our series on AI for the clinician! Large language models, like ChatGPT, have been taking the world by storm, and healthcare is no exception to that rule – your institution may already be using them! In this episode we'll tackle the fundamentals of how they work and their applications and limitations to keep you up to date on this fast-moving, exciting technology. Hosts: Ayman Ali, MD Ayman Ali is a Behind the Knife fellow and general surgery PGY-3 at Duke Hospital in his academic development time where he focuses on data science, artificial intelligence, and surgery. Ruchi Thanawala, MD: @Ruchi_TJ Ruchi Thanawala is an Assistant Professor of Informatics and Thoracic Surgery at Oregon Health and Science University (OHSU) and founder of Firefly, an AI-driven platform that is built for competency-based medical education. In addition, she directs the Surgical Data and Decision Sciences Lab for the Department of Surgery at OHSU.  Phillip Jenkins, MD: @PhilJenkinsMD Phil Jenkins is a general surgery PGY-3 at Oregon Health and Science University and a National Library of Medicine Post-Doctoral fellow pursuing a master's in clinical informatics. Steven Bedrick, PhD: @stevenbedrick Steven Bedrick is a machine learning researcher and an Associate Professor in Oregon Health and Science University's Department of Medical Informatics and Clinical Epidemiology. Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.  If you liked this episode, check out our recent episodes here: https://app.behindtheknife.org/listen

Welcome to our new series – the AI Journal Club! In this series, we'll cover some interesting studies and evidence-based applications of artificial intelligence in surgery in a case-based format. Surely AI can find a DVT by now … or can it? Stay tuned and find out! Hosts: - Ayman Ali, MD Ayman Ali is a Behind the Knife fellow and general surgery PGY-3 at Duke Hospital in his academic development time where he focuses on data science, artificial intelligence, and surgery. - Ruchi Thanawala, MD: @Ruchi_TJ Ruchi Thanawala is an Assistant Professor of Informatics and Thoracic Surgery at Oregon Health and Science University (OHSU) and founder of Firefly, an AI-driven platform that is built for competency-based medical education. In addition, she directs the Surgical Data and Decision Sciences Lab for the Department of Surgery at OHSU.  - Marisa Sewell, MD: @MarisaSewell Marisa Sewell is a general surgery PGY-4 at Oregon Health and Science University.  Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://app.behindtheknife.org/listen

CTX is a rare metabolic disease that can cause seizures, developmental delays, and intellectual disability. Now, a diagnostic test that can detect the condition early is available, and a treatment that can prevent the disease's serious effects has won regulatory approval. We spoke to Bart Duell, professor of medicine at Oregon Health Sciences University, about CTX, the role OHSU played in developing a diagnostic and advancing a treatment for CTX; and the critical interplay between academic medical centers, patient advocates, and drug developers to address the needs of people with rare diseases.

An interview with Shannon Droning, Consumer and Specialty Market President of Providence Health Plan, Dr. Abby Khan, OHSU cardiologist, Dr. Amit Kansara, Providence neurologist, and Matthew Kampfe, Brain Rehab Network President. All are volunteers with the American Heart Association. We discuss heart disease and stroke causes and prevention and talk about the AHA Heart and Stroke Walks in Vancouver and Portland.

 On Monday, Oregon Health and Science University and Legacy Health announced they are mutually walking away from an effort to combine the two healthcare organizations. The merger was first announced last August, when OHSU agreed to acquire 8 hospitals, $3 billion in assets and promised a whopping $1 billion in upgrades to Legacy facilities. The merger garnered scrutiny from a citizen review committee and public comments have reflected opposition to the deal. Amelia Templeton is OPB’s Healthcare reporter and has been following this story. She joins with the latest.

Join Elevated GP: www.theelevatedgp.com Free Class II Masterclass - Click Here to Join Follow @dental_digest_podcast Instagram Follow @dr.melissa_seibert on Instagram Dr. Stanley Liu (“Leo”) received his undergraduate education from Stanford University. He completed DDS and MD degrees, with General Surgery internship and Oral & Maxillofacial Surgery residency, from the University of California – San Francisco (UCSF). After Sleep Surgery Fellowship at Stanford Medical School in 2014, he was appointed faculty in the Department of Otolaryngology until 2023. He rose to the rank of Associate Professor, and Director of the Sleep Surgery Fellowship. Concurrently, he was a Preceptor of the Oculoplastic Surgery Fellowship and held a courtesy appointment to the Division of Plastic & Reconstructive Surgery.  In February 2024, he joined Nova Southeastern University as the Chair of the Department of Oral & Maxillofacial Surgery, and Assistant Dean of Hospital Affairs. Dr. Liu is a Fellow of the American College of Surgeons (FACS), and the American College of Oral & Maxillofacial Surgeons. He has been a Howard Hughes Medical Institute (HHMI) Scholar, and Stanford Biodesign Faculty Fellow. He serves on the board or executive positions of the California Sleep Society (CSS), American Academy of Physiologic Medicine & Dentistry (AAPMD), and the World Dentofacial Sleep Society (WDSS). He is a consultant member in the sleep section of the American Academy of Otolaryngology – Head & Neck Surgery (AAO-HNS). Dr. Liu's clinical and research focus are on surgical approaches to obstructive sleep apnea. With his surgical mentor and sleep surgery pioneer, Dr. Robert Riley, the Stanford Sleep Surgery approach was updated to integrate drug-induced sleep endoscopy (DISE), nasal surgery including maxillary expansion (DOME), pharyngeal surgery (UPPP), hypoglossal nerve stimulation (HGNS), and maxillomandibular advancement (MMA).  His bibliography lists over 90 journal articles and 20 book chapters. He has been a Grand Rounds speaker at academic programs including UCSF, Northwestern, OHSU, LSU, and Stanford. He has been a Keynote Speaker for preeminent sleep and surgery meetings, including the 33rd SLEEP in 2019, and World Sleep in 2023.

  Join Elevated GP: www.theelevatedgp.com Free Class II Masterclass - Click Here to Join Follow @dental_digest_podcast Instagram Follow @dr.melissa_seibert on Instagram Dr. Stanley Liu (“Leo”) received his undergraduate education from Stanford University. He completed DDS and MD degrees, with General Surgery internship and Oral & Maxillofacial Surgery residency, from the University of California – San Francisco (UCSF). After Sleep Surgery Fellowship at Stanford Medical School in 2014, he was appointed faculty in the Department of Otolaryngology until 2023. He rose to the rank of Associate Professor, and Director of the Sleep Surgery Fellowship. Concurrently, he was a Preceptor of the Oculoplastic Surgery Fellowship and held a courtesy appointment to the Division of Plastic & Reconstructive Surgery.  In February 2024, he joined Nova Southeastern University as the Chair of the Department of Oral & Maxillofacial Surgery, and Assistant Dean of Hospital Affairs. Dr. Liu is a Fellow of the American College of Surgeons (FACS), and the American College of Oral & Maxillofacial Surgeons. He has been a Howard Hughes Medical Institute (HHMI) Scholar, and Stanford Biodesign Faculty Fellow. He serves on the board or executive positions of the California Sleep Society (CSS), American Academy of Physiologic Medicine & Dentistry (AAPMD), and the World Dentofacial Sleep Society (WDSS). He is a consultant member in the sleep section of the American Academy of Otolaryngology – Head & Neck Surgery (AAO-HNS). Dr. Liu's clinical and research focus are on surgical approaches to obstructive sleep apnea. With his surgical mentor and sleep surgery pioneer, Dr. Robert Riley, the Stanford Sleep Surgery approach was updated to integrate drug-induced sleep endoscopy (DISE), nasal surgery including maxillary expansion (DOME), pharyngeal surgery (UPPP), hypoglossal nerve stimulation (HGNS), and maxillomandibular advancement (MMA).  His bibliography lists over 90 journal articles and 20 book chapters. He has been a Grand Rounds speaker at academic programs including UCSF, Northwestern, OHSU, LSU, and Stanford. He has been a Keynote Speaker for preeminent sleep and surgery meetings, including the 33rd SLEEP in 2019, and World Sleep in 2023.

Oregon Health & Science University began its Long COVID-19 clinic in 2021, a year into the pandemic as the first vaccines were just becoming widely available. We talked with doctors in the clinic in 2022, and we wanted to check back in to see what clinicians have learned after treating thousands of long COVID patients. Aluko Hope is a pulmonologist, critical care doctor and the medical director of OHSU’s Long COVID-19 program. Jen Arnold is a lead nurse with the program. They both join us to tell us what they’ve learned about caring for patients with long COVID in the last four years and what they hope to learn more about from the research that’s currently underway.

SIIMCast takes a detour from its usual deep dives into imaging informatics to explore the quirky, vibrant city of Portland, Oregon—host of the 2025 SIIM Annual Meeting! Join us as we chat with Portland-based radiologist Dr. Neel Patel and SIIMCast co-founder Dr. Prasanth Prasanna, who doubles as both host and local guide. From legendary donuts to iconic bookstores, scenic hikes to top-notch pizza, and even whiskey libraries, we cover everything you need to know to make the most of your trip. Plus, we touch on Portland's growing role in radiology and informatics, including insights into OHSU, PACS transitions, and the future of AI in workflow optimization. Whether you're attending SIIM 2025 or just curious about Portland, this episode has something for everyone. Tune in for the ultimate Portland primer—no raincoat required! SIIM25 Registration and Details: https://annualmeeting.siim.org/

But will it be a home run? The Portland Diamond Project has so far struck out on its years-long efforts to bring Major League Baseball to Portland. But now they've got a new site on the South Waterfront, fresh energy from city leaders and a pitch to the Oregon Legislature, not to mention swoon-y renderings of a new stadium along the Willamette. Sports columnist Bill Oram and ECONorthwest economist Mike Wilkerson join Beat Check with The Oregonian to make sense of the numbers behind the proposal, the unknowns (who is behind that ownership group?) and what comes next. Wilkerson, a consultant to the Portland Diamond Project, says building a new stadium downtown could be a game-changer for Portland, the city that he recently and regretfully said was on the verge of a “doom loop” thanks to downward trends in population growth, the commercial real estate market and more. Stay tuned until the end of the episode to hear Oram and Wilkerson make it very clear where their own personal baseball allegiances land. Related coverage: Is a picture worth almost a billion dollars?OHSU responds to South Waterfront ballpark proposalEconomist warns of Portland ‘doom loop' Subscribe to Beat Check anywhere you listen to podcasts to get new episodes each week. You can support local journalism by becoming a subscriber to The Oregonian/OregonLive. Explore more of our podcasts and sign up to get newsletters for the latest news and top stories. Learn more about your ad choices. Visit megaphone.fm/adchoices

An estimated 650,000 adults in Bangladesh suffer from blindness, according to researchers. At the end of November, Oregon Health & Science University ophthalmologist Beth Edmunds traveled to the country to teach local doctors a minimally-invasive operation for adults and children with glaucoma. She joins us to share what she took away from her time volunteering and what it was like operating in the world’s only flying teaching hospital. 

Federal workforce layoffs, funding freezes, and internet beef between two Pacific Northwest mountains are on the table for today's midweek roundup. There's also news from OHSU about a new early-detection test for pancreatic cancer and comments from our listener mailbag. Joining host Claudia Meza on this midweek roundup is our very own senior producer, Giulia Fiaoni. Discussed in Today's Episode:  Mass Layoffs at Bonneville Power Administration Raise Concerns About Reliability of Power Grid [KGW] Oregon Senators Call for Federal Firefighters To Be Exempt From Hiring Freeze [OPB] OHSU Researchers Develop Test for Earlier Detection of Pancreatic Cancer [Wilamette Week] Court Pause on Trump Cuts to Medical Research Funds Is Expanded Nationwide [New York Times]  Become a member of City Cast Portland today! Get all the details and sign up here. Who would you like to hear on City Cast Portland? Shoot us an email at portland@citycast.fm, or leave us a voicemail at 503-208-5448. Want more Portland news? Then make sure to sign up for our morning newsletter, Hey Portland, and be sure to follow us on Instagram.  Looking to advertise on City Cast Portland? Check out our options for podcast and newsletter ads at citycast.fm/advertise. Learn more about the sponsors of this February 19th episode: Babbel - Get up to 60% off at Babbel.com/CITYCAST Treefort Music Fest Portland Jazz Festival Learn more about your ad choices. Visit megaphone.fm/adchoices

Oregon Health & Science University has been facing a series of mounting challenges in recent months, including its proposed merger with Legacy Health, which is being reviewed by the Oregon Health Authority. If approved, OHSU would control five of the six hospitals in Multnomah County, according to a report issued by OHA last November.  OHSU has also had to contend with the departure of prominent executives such as the interim head of its health unit last month, and Dr. Brian Druker, a world renowned cancer researcher, who resigned in December as CEO of the Knight Cancer Institute. Among the reasons Druker shared with OPB for his decision included low staff morale, a lack of trust in OHSU’s leaders and the organization’s cost-cutting measures, such as its decision to lay off more than 500 employees.  Leading OHSU during this turbulent time is Steve Stadum. The board of directors appointed him as interim president in November, marking his return to the organization which he first worked at more than 25 years ago. Stadum joins us to share his vision for OHSU and how he aims to navigate its internal and external challenges, including threats to federally funded research from the new Trump administration.  

A new study made national headlines, estimating that in the next three decades, around 42% of adults over the age of 55 will develop dementia. Allison Lindauer is an associate professor of neurology at the Oregon Alzheimer’s Disease Research Center at OHSU. She joins us to share what we know about dementia and what people can do to prevent it.

In this episode we talked to Neuroscientist Dr. Larry Sherman of OHSU about the upcoming Romance, Love Songs, and Neuroscience event coming up this valentines day. We also talked to the Wiggles, an internationally famous group, who will be in concert in Portland on June 5th for their Bouncing Balls Tour.

The fentanyl crisis has taken a toll on communities all across Oregon. It has also shined a light on the challenges frontline responders face when trying to get people help for substance use disorder, especially in rural areas and jails or prisons where treatment can be hard to obtain.   But a training program in addiction medicine offered by OHSU is providing help by sharing resources, best practices and collaborative problem solving on complex cases. While most of the people who enroll in the course, which is taught remotely, work in healthcare, it’s attracting growing interest among law enforcement. Enrollment overall in the training program has grown by nearly two-thirds in the past two years. Dan Hoover, an assistant professor of medicine and the director of the Extension for Community Health Outcomes addiction medicine program at OHSU, joins us for more details.

Animals such as grizzly bears and Arctic ground squirrels have evolved the ability to hibernate as a way to survive winter months of extreme cold. During hibernation, their core body temperatures drop and their heart rates and metabolic activities slow to conserve energy. They also consume less oxygen during this inactivity.    But what if you could make non-hibernating species – including humans - hibernate? How could you control hibernation as a therapy to help people recover from strokes or heart attacks, or administer it to astronauts to help them endure a yearslong trip to Mars? Scientists at Oregon Health & Science University have embarked on a first step to exploring these questions by inducing a state of hibernation in rats, which don’t normally hibernate. Joining us to discuss this research is Domenico Tupone, a research assistant professor of neurology at OHSU.

According to the CDC, more than 2 million people in the U.S. are infected with hepatitis C. The bloodborne illness attacks the liver and can lead to cancer or death if left untreated. Injection drug use is the leading risk factor for hepatitis C, which is also more prevalent in rural counties where diagnosis and treatment can be hard to come by, especially for people experiencing homelessness.  Scientists at Oregon Health and Science University demonstrated a new strategy that could significantly boost the diagnosis and successful treatment of hepatitis C in rural communities. In a recently published study, they showed that peers with lived experience in drug use were able to successfully enroll and facilitate treatment for people who tested positive for hepatitis C in six rural Oregon counties using telemedicine, which was seven times more effective than referrals to clinics for in-person treatment. Joining us to talk about the results and the role peer specialists can play to combat the spread of hepatitis C is Dr. Andrew Seaman, an associate professor of medicine at OHSU, the medical director of HIV and hepatitis C services at Central City Concern and head of substance use disorder programs at Better Life Partners in New England.  

Oregon Health & Science Institute's online training program is reaching more Oregon professionals in healthcare and law enforcement.

In this episode of the Becker's Healthcare Podcast, Dr. John Hunter, former CEO of OHSU and expert esophageal surgeon, discusses the evolving dynamics between healthcare executives and physicians in a post-pandemic world. From the rise of physician unionization to fostering sustainable work environments and aligning missions, Dr. Hunter shares valuable insights and advice for healthcare leaders striving to create meaningful change in their organizations and communities.

If you're an ASOPRS Member, Surgeon or Trainee and are interesting in hosting a podcast episode, please submit your idea by visiting: asoprs.memberclicks.net/podcast About the Guests: Dr. Roger A. Dailey, MD, FACS: He is a renowned ophthalmologist and faculty member at Oregon Health & Science University, specializing in oculoplastics. Dr. Dailey has a vast professional history, starting his residency in 1983, and has made significant contributions to the development of oculoplastic procedures and education. Dr. Jack Wobig, MD, MBA, FACS: A retired ophthalmologist with a rich legacy in oculoplastic and orbital surgery. Dr. Wobig was a key figure at OHSU and spent decades in private practice and teaching, contributing significantly to the field through his research and collaborations, most notably with Lester Jones. Dr. Andrew Harrison, MD: An oculoplastic and orbital surgeon at the University of Minnesota, Dr. Harrison is well-versed in advanced surgical techniques. He completed his fellowship with Dr. Wobig and Dr. Dailey and continues to advance the field through both his surgical practice and academic contributions. Episode Summary: In this engaging episode of the ASOPRS podcast, hosts Dr. Roger Dailey and Dr. Andrew Harrison are joined by the legendary Dr. Jack Wobig to delve into the rich history and evolution of oculoplastic surgery. The conversation hones in on Dr. Wobig's remarkable career, including his professional journey, collaborations with Lester Jones, and the innovative development of the Jones tube for lacrimal duct surgeries. This episode not only offers a window into the pioneers of oculoplastics but also provides valuable insights for future surgeons. Throughout the discussion, the guests highlight various milestones in the field of oculoplastics, emphasizing the importance of anatomical precision and collaboration in surgical innovations. The trio reminisces about shared experiences, with anecdotes that underscore the transformative impact of their mentors and colleagues. By examining the past and contemplating future challenges and opportunities, the episode paints a comprehensive picture of the field's trajectory. Insights into educational practices, the expanding global impact of Aesoppers, and the evolving dynamics of surgical training provide both a nostalgic and forward-looking view on the practice of oculoplastics. Key Takeaways: Historical Insights: Exploration of Dr. Jack Wobig's collaboration with Lester Jones in developing the Jones tube and its impact on lacrimal surgery. Evolution of ASOPRS: Discussion on the early days of ASOPRS, its formation, and Dr. Wobig's presidency, highlighting the challenges and growth in training and standards enforcement. Educational Influence: Reflections on the importance of international exposure and collaboration in shaping successful careers in oculoplastics. Retirement Advice: Dr. Wobig shares perspectives on retirement, the value of lifelong learning, and the fulfillment derived from a meaningful career and rich family life. Lifelong Relationships: Emphasis on the importance of maintaining connections with colleagues and fellows, fostering a family-like environment within the surgical community.

It’s been a few years, but we are here with an update on acromegaly, covering prevalence, diagnosis, traditional treatment, new therapies, and current gaps in understanding. Host Aaron Lohr talks again with Maria Fleseriu, MD, professor of medicine and professor of neurological surgery at Oregon Health & Science University School of Medicine and director of OHSU’s Pituitary Center. Dr. Fleseriu also serves on the Board of Directors of the Endocrine Society. Show notes are available at https://www.endocrine.org/podcast/enp94-update-on-acromegaly — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

From cable grafts to free muscle transfer, surgical treatments for facial paralysis are evolving quickly. In this episode of the Backtable ENT Podcast, Dr. Myriam Loyo Li, facial plastic surgeon at OHSU, joins guest host Dr. Shiayin Yang of Vanderbilt to discuss dynamic procedures for facial paralysis. --- This podcast is supported by: BackTable + ENT https://www.backtable.com/shows/ent --- SYNPOSIS First, the surgeons review workup of flaccid and non-flaccid (synkinetic) facial paralysis. Then, they review the principles of facial reanimation. Topics such as nerve graft selection and staged surgery are covered. Dr. Loyo Li explains her timelines for staged surgery and how patient characteristics affect her decision planning. Finally, the surgeons discuss free muscle transfer – an exciting new technique in the world of facial plastic surgery – to treat facial paralysis. --- TIMESTAMPS 00:00 - Introduction 02:48 - Evaluating and Managing Flaccid Facial Palsy 05:18 - Imaging and Treatment Pathways 07:16 - Nerve Grafting Techniques and Preferences 10:08 - Challenges and Innovations in Facial Reanimation 25:50 - Patient-Centered Approaches and Decision Making 37:30 - Evaluating Facial Nerve Recovery 43:25 - Timing and Criteria for Nerve Transfers 46:41 - Free Muscle Transfer Techniques 49:47 - Innovations in Cross Facial Nerve Grafts 01:06:04 - Exploring Free Strap Muscle Transfers 01:14:05 - The Future of Facial Reanimation --- RESOURCES Dr. Loyo Li's OHSU Profile: https://www.ohsu.edu/providers/myriam-loyoli-md-mcr Dr. Yang's Vanderbilt Profile: https://www.vanderbilthealth.com/doctors/yang-shiayin

Menopause can present a wide range of symptoms, from hot flashes and sleep disturbances to brain fog and loss of bone density. Though several safe and effective therapies are available, many patients still aren’t receiving the help they need. A new study from Oregon Health & Science University found that more than 60% of respondents with moderate to severe menopause symptoms weren’t receiving any treatment. The primary reason they reported not engaging in treatment was that their clinician hadn’t recommended it to them. Maria Rodriguez is a professor of obstetrics and gynecology at OHSU and the director of the university’s Center for Reproductive Health Equity. Sara Cichowski is the university’s vice chair of gynecology and an assistant professor of obstetrics and gynecology. They both join us to talk more about the barriers to accessing menopause care in Oregon.

In this episode, we speak with Dr. Eneida Nemecek, a pediatric oncologist specializing in bone marrow transplants and cellular therapies. Dr. Nemecek provides an in-depth look at the science behind these treatments, the process patients go through, and the challenges faced by both patients and caregivers. She emphasizes the importance of caregiver well-being, particularly sleep, and discusses a PCORI study on stress management for caregivers. The episode concludes with a rapid-fire Q&A session covering key terms and concepts in the field. This episode was supported by the Patient Centered Outcomes Research Institute (PCORI) and features these PCORI studies (Study #1 & Study #2) by Mark Laudenslager, PhD. Key Highlights: 1. Bone marrow transplant involves replacing a patient's immune system with a healthier one, either from a donor or the patient's own modified cells. 2. Caregiver quality of life, especially sleep, is crucial for patient outcomes in bone marrow transplant cases. 3. CAR-T therapy is a form of cellular therapy where white blood cells are engineered to attack specific targets, offering new treatment options for certain cancers. About our guest: Dr. Eneida Nemecek is a Professor of Pediatrics and Medical Oncology and Associate Director of Clinical Research at the Knight Cancer Institute-Oregon Health & Science University (OHSU) in Portland, Oregon. Native from Puerto Rico, she completed her Pediatric residency at Case Western Reserve University in Cleveland, OH and Pediatric Hematology/Oncology fellowship at the Fred Hutchinson Cancer Research Center in Seattle, Washington. She has a Master in Epidemiology and Clinical Research from the University of Washington and a Master in Healthcare Business Administration from OHSU. Dr. Nemecek is an established clinical researcher with over 20 years of experience in trials ranging from investigator-initiated early phase to large, multicenter studies funded by a variety of mechanisms.  Her research focuses on bone marrow and cellular therapies, experimental oncology therapeutics and health services research addressing disparities in access for underrepresented groups. She has served in leadership roles in steering committees for several national cooperative research groups.  She has also held elected leadership positions as director, trustee or committee chair in multiple professional organizations. The Your Cancer GPS™ platform is coming! Step-by-step subway maps that guide you through the entire cancer experience. Learn more here!⁠ Key Moments: At 14:40 “Sleep is healthy. If you are the one caregiver of a patient and you get sick because you're stressed and not getting enough rest, then you get affected and your patient gets affected too. It's a very important part of our health. Eat, sleep, get some time for yourself. Those are all things that just need to happen. The way that we're designing medicine today, sometimes we forget that the caregiver is kind of a patient. If we lose that person, we are in serious trouble. I can tell you multiple examples about when that has happened and how difficult it is for the medical team and for the family.” At 28:03 “I think it's really important to remind ourselves that the brain, our psychosocial life, is part of our health. I think sleep, exercise, diet studies, anything that can improve the life of people should be studied in a very organized setting, just like you study drugs, if we're going to do this well.” Disclaimer: All content and information provided in connection with Manta Cares is solely intended for informational and educational purposes only.  This content and information is not intended to be a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

UNLOCKING ULTIMATE HEALTH & REDUCING CHRONIC DISEASE RISK with guest expert Dr. Casey MeansFeeling overwhelmed trying to reach optimal health? Are you done with fatigue, brain fog, anxiety, gut issues, and want to avoid or reverse type 2 diabetes while keeping cancer, heart disease and neurodegenerative disorders at bay?Dr. Casey Means joins me to break down all the mitochondrial dysfunction dragging you down while offering her top tips to boost your energy and improve your overall well-being as well as what biomarker tests to take and keep an eye on. Ready for 10 key insights to help you thrive? Let's dive in! In this episode, you'll learn about:Metabolic Health: How metabolic function (or dysfunction) affects overall health and longevity.Biomarkers: Using biomarkers such as fasting glucose and HDL to assess and improve metabolic health.Lifestyle Changes: Why adopting a whole foods, plant-based diet and cutting down on processed foods will give you the "Good Energy" you need.Metabolic Dysfunction: Links between metabolic issues and chronic diseases like heart disease, diabetes, and Alzheimer's.Healthcare Costs: Comparing treatment of symptoms versus preventative measures for chronic diseases.Our Healthcare System: Why it is failing you and how to take back power.Cellular Energy: Enhancing cellular energy through easy lifestyle adjustments.Artificial Light: How artificial light disrupts circadian rhythms and metabolic processes.Exercise: Benefits you may not know you don't know of various exercises, including HIIT, resistance training, and walking, for metabolic health.Environmental Toxins: Reducing exposure to environmental toxins through mindful product ABOUT OUR GUEST EXPERT:Casey Means, MD is a Stanford-trained physician, Chief Medical Officer and Co-founder of metabolic health company Levels, and Associate Editor of the International Journal of Disease Reversal and Prevention.She has held research positions at NIH, Stanford, NYU, OHSU and besides being an M.D. is also an AFMCP from the Institute for Functional Medicine.**************************************Control YOUR glucose regulation & learn with a CGM!Get your own CONTINUOUS GLUCOSE MONITOR (CGM) with these two favorites:ZOE -- Visit https://joinzoe.com/ and use code: SAMANTHA10 for 10% off**BONUS -- Zoe not only allows you to know your glucose levels, but also includes learning about your microbiome's good and bad gut bugs with a stool test AND a blood fat breakdown with the included blood test for triglycerides.NUTRISENSE -- Visit: https://bit.ly/NutrisenseCGM-SH25 -- for $25 off your CGM (or you can also use code: SAMANTHAHARRIS25). The app is super easy to navigate and understand PLUS you get a BONUS of free nutritionist guidance for the first month (and can add on more months after that for a fee).**************************************MORE FUN FROM SAMANTHA:Get my favorite, clean supplements, protein powders, and EWG-Verified clinically proven anti-aging skincare

Hardly a week goes by in the U.S. without a mass shooting, as the recent shooting at a high school in Georgia earlier this month reminds us of. In that tragedy, a 14-year-old student is suspected of killing two students and two teachers with a semiautomatic assault-style rifle which was legally purchased by his father. The National Rifle Association, along with some conservative lawmakers and the gun lobby argue that mental illness is to blame for mass shootings – not the easy access to firearms.  A new study by researchers at Oregon Health & Science University challenges that view. It compared the U.S. to 40 other countries for the prevalence of mental health disorders and deaths from firearms over a 20-year period, from 2000 to 2019. It found that death by firearms was 20 times greater in the U.S. compared to the other nations, while the prevalence of mental health disorders in the U.S. was similar. It also found that the firearm death rate decreased, on average, in those other countries whereas it increased sharply in the U.S. over that timeframe. Joining us to share details about the study is Archie Bleyer, a pediatric and young adult oncologist at OHSU. 

Hardly a week goes by in the U.S. without a mass shooting, as the recent shooting at a high school in Georgia earlier this month reminds us of. In that tragedy, a 14-year-old student is suspected of killing two students and two teachers with a semiautomatic assault-style rifle which was legally purchased by his father. The National Rifle Association, along with some conservative lawmakers and the gun lobby argue that mental illness is to blame for mass shootings – not the easy access to firearms.  A new study by researchers at Oregon Health & Science University challenges that view. It compared the U.S. to 40 other countries for the prevalence of mental health disorders and deaths from firearms over a 20-year period, from 2000 to 2019. It found, for example, that the firearm death rate was 11 times greater in the U.S. compared to the other nations while the prevalence of mental health disorders in the U.S. was similar. It also found that the firearm death rate in the U.S. had increased, whereas it declined among the other nations. Joining us to share details about the study is Archie Bleyer, a pediatric and young adult oncologist at OHSU.  Read on-air: The Great Salt Lick auction will take place this Saturday at 6 p.m. at the Churchill School in Baker City. Attendance is free.  

U.S. Surgeon General Dr. Vivek H. Murthy recently issued an advisory saying stress from parenting is a public health issue. The nation's doctor shared his concerns over the well-being of parents, noting overwhelming stressors affecting parents today – from financial pressures to worries around kids' health and safety. The advisory notes that nearly half of parents say most days their stress is overwhelming and more than 40% say they are so stressed they cannot function. Marlo McIlraith is an associate professor of pediatrics and a pediatrician at OHSU. She joins us to share more on what is causing more parents to be stressed today and ways she recommends they try to help deal with these emotions.

Join for the fifth episode in the Association of Out Surgeons and Allies (AOSA) series for a comprehensive discussion of what the general surgeon needs to know prior to operating on a patient who has previously undergone gender affirming surgery. Host:  Dan Scheese, MD Andrew Schlussel, DO, Colorectal and General Surgeon, Charlie Norwood VA Medical Center Guests: Dr. Megan Lane (She/her) megalane@med.umich.edu Dr. Lane is a plastic surgery resident at the University of Michigan who is planning on going into Gender Affirming Surgery and general reconstruction. She completed a research fellowship in the National Clinician Scholars Program and focused primarily on patient-reported outcomes in gender affirming surgery. Dr. Amy Suwanabol pasuwan@med.umich.edu Dr. Suwanabol is a colorectal surgeon at the University of Michigan and the Ann Arbor VA. She assists the gender affirming surgeons at the University of Michigan in performing robotic-assisted vaginoplasty. Her research focuses on optimizing quality of life among surgical patients and their families, surgeon well-being, and cancer survivorship. Dr. Monica Llado-Farrulla lladorfar@ohsu.edu Dr. Llado-Farrulla was born and raised in Puerto-Rico, completed general surgery residency followed by plastic surgery residency at Tulane and Penn, respectively. She pursued a year of training in advanced gender surgery and is now currently at OHSU. Her practice largely focuses on facial feminization, chest affirming surgeries, phalloplasty, autologous breast reconstruction, and limb salvage.  Learn more and get involved with AOSA: https://www.outsurgeons.org Twitter/X: @OutSurgeons Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://app.behindtheknife.org/listen

The birth of a baby is often celebrated as a joyful and natural process, but it can also be physically and emotionally traumatic. The Perinatal Trauma Clinic at Oregon Health & Science University is one of only a handful nationwide that aims to support parents who have experienced trauma around birth or pregnancy. Patients work with both mental and physical health care providers at the Center for Women’s Health to develop a plan that fits their personal circumstances.   Katie Au and Katherine Jorda are both associate professors of obstetrics and gynecology at OHSU. They co-direct the clinic and join us with more details about the care they provide.

What is a healthy diet and how much does it really matter that we try to eat one as we age?  That's the topic of this week's podcast with three amazing guests: Anna Pleet, Elizabeth Eckstrom, and Emily Johnston. Emily Johnston is a registered dietitian, nutrition researcher, and Assistant professor at NYU.  Anna Pleet is an internal medicine resident at Allegheny Health Network who has a collection of amazing YouTube videos on aging and the Mediterranean diet. Elizabeth Eckstrom is a geriatrician, professor of medicine at OHSU, and author of a new book, the Gift of Aging. I love this podcast as while we talk about the usual topics in a medical podcast, like the role of screening, energy balance, and evidence-based for specific diets, we also talk about what a Mediterranean diet actually looks like on a plate and pepper our guests with questions about their favorite meals to convince Alex and me to eat more like a Sardinian. Eric PS.  NEJM just published a great summary of diets summing up adherence to the Mediterranean diet and the following improved health outcomes: death from any cause, cardiovascular diseases, coronary heart disease, myocardial infarction, cancer, neurodegenerative diseases, and diabetes    

Today, Fei and Nick are joined by Dr. Molly Kornfield, previously REI fellow and now assistant professor of reproductive endocrinology and infertility at OHSU. She tells us all about hyperprolactinemia: how we diagnose it, evaluate it, and treat it!  Twitter: @creogsovercoff1 Instagram: @creogsovercoffee Facebook: www.facebook.com/creogsovercoffee Website: www.creogsovercoffee.com Patreon: www.patreon.com/creogsovercoffee You can find the OBG Project at: www.obgproject.com

Join for the forth episode in the Association of Out Surgeons & Allies (AOSA) series for a discussion on gender affirming care and gender affirming surgery. Host: Dan Scheese, MD Andrew Schlussel, DO, Colorectal and General Surgeon, Charlie Norwood VA Medical Center Guests: 1. Dr. Megan Lane (She/her) megalane@med.umich.edu Dr. Lane is a Plastic Surgery resident at the University of Michigan who is planning on going into Gender Affirming Surgery and general reconstruction, she completed a research fellowship in the National Clinician Scholars Program and focused primarily on patient-reported outcomes in gender affirming surgery.  2. Dr. Scott Chaiet (he/him/his/himself) chaiet@surgery.wisc.edu Dr. Chaiet is double board certified by the American Board of Otolaryngology and the American Board of Facial Plastic & Reconstructive Surgery and is currently at the University of Wisconsin. His areas of expertise include rhinoplasty and facial gender surgery. He also practices reconstructive surgery including facial paralysis reanimation. His gender affirming practice includes all areas of the face and Adam's apple except for hair. 3. Dr. Amy Suwanabol  pasuwan@med.umich.edu Amy Suwanabol is a colorectal surgeon at the University of Michigan and the Ann Arbor VA. She assists the gender affirming surgeons at the University of Michigan in performing robotic assisted vaginoplasty. Her research focuses on optimizing quality of life among surgical patients and their families, surgeon well being, and cancer survivorship.   4. Dr. Monica Llado-Farrulla lladofar@ohsu.edu Dr. Llado-Farulla was born and raised in Puerto Rico, completed a residency in general surgery and then plastic surgery at Tulane and Penn, respectively. She pursued a year of training in advanced gender surgery and is now currently at OHSU, her practice largely focuses on facial feminization, chest affirming surgeries, phalloplasty, autologous breast reconstruction, and limb salvage.  5. Dr. Michele “Mike” Fascelli (he/him/his) FASCELM2@ccf.org Dr. Fascelli is a practicing reconstructive urologist at Cleveland Clinic.  He comppleted his urology training at the Cleveland Clinic in Ohio and then fellowship in urogenital gender affirming surgery with the urology team at OHSU with Dr. Llado-Farulla. He is now the Director of Urogenital Reconstruction and Co-Director of the Gender Affirming Surgery Program at Cleveland Clinic.  He is very committed to LGBTQIA+ urologic access and actively works to protect and expand care to the rainbow community, and to our trans and gender diverse patients.  His practice is currently focused on queer urologic health concerns and genital gender surgery (i.e. vaginoplasty, metoidioplasty and phalloplasty).     Learn more and get involved with AOSA: https://www.outsurgeons.org Twitter/X: @OutSurgeons   Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://app.behindtheknife.org/listen